WBASNY Letter to FDA Regarding Emergency Contraceptives

Recommending the approval of the proposal made by Duramed Research, Inc. as a positive first step toward allowing Plan B contraceptives to be marketed with appropriate safeguards, see the letter WBASNY President Andrea Phoenix wrote to the FDA.